Multiple Myeloma — Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
Citation(s)
An Open-Label Phase I Study of the Safety of Perifosine in Combination With Lenalidomide and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma